MedPath

Biomarker Sub Study of the Compression Stockings to Prevent the Post-Thrombotic Syndrome (SOX) Trial

Completed
Conditions
Deep Venous Thrombosis
Registration Number
NCT01615705
Lead Sponsor
Sir Mortimer B. Davis - Jewish General Hospital
Brief Summary

The purpose of this study is to evaluate whether biomarkers of inflammation, genetic thrombophilia and coagulation activation influence Post-Thrombotic Syndrome development in patients with symptomatic proximal deep venous thrombosis.

Detailed Description

The post-thrombotic syndrome (PTS) is a frequent, burdensome and costly condition that occurs in about one third of patients after an episode of deep vein thrombosis (DVT). Affected patients have chronic leg pain and swelling, and sometimes develop skin ulcers. Poor understanding of the pathophysiology and predictors of PTS has hampered progress in its prevention and treatment. Biomarkers reflective of inflammation, genetic thrombophilia and coagulation activation may be of value in predicting PTS development in patients with DVT; they may also provide insight into understanding the underlying mechanisms of PTS, which could result in the development and testing of novel therapies to prevent and treat PTS.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
803
Inclusion Criteria
  • Consecutive patients with a first, symptomatic, objectively confirmed proximal DVT diagnosed within the last 14 days (with or without concurrent distal DVT or pulmonary embolism)
  • Who have no contraindications to standard treatment with heparin and/or warfarin, and
  • Who provide informed consent to participate
Exclusion Criteria
  • Contraindication to compression stockings Limited lifespan (estimated < 6 months)
  • Geographic inaccessibility preventing return for follow-up visits
  • Inability to apply stockings daily and unavailability of a caregiver to apply stockings daily
  • Treatment of acute DVT with thrombolytic agents

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Markers of Inflammation6-month follow up

Blood samples drawn at baseline, 1 and 6-mths to evaluate the relationship between CRP, ICAM, IL-6, IL-10 with the subsequent development of PTS.

Markers of Other Thrombophilia6-month follow up

Blood samples drawn at 6-mths to evaluate the relationship between D-Dimer, VIII, Lupus anticoagulant, IgG, IgM with the subsequent development of PTS.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (25)

St. Boniface General Hospital

🇨🇦

Winnipeg, Manitoba, Canada

Henry Ford Health System

🇺🇸

Detroit, Michigan, United States

Oklahoma University Health Sciences Center

🇺🇸

Oklahoma City, Oklahoma, United States

Victoria Heart Institute Foundation

🇨🇦

Victoria, British Columbia, Canada

Duke University Medical Center

🇺🇸

Durham, North Carolina, United States

QE II Health Sciences Centre

🇨🇦

Halifax, Nova Scotia, Canada

Hamilton Health Sciences - General Hospital

🇨🇦

Hamilton, Ontario, Canada

Hamilton Health Sciences - Chedoke Division

🇨🇦

Hamilton, Ontario, Canada

Hamilton Health Sciences - McMaster University Medical Centre

🇨🇦

Hamilton, Ontario, Canada

Hamilton Health Sciences - Henderson General Hospital

🇨🇦

Hamilton, Ontario, Canada

London Health Sciences Centre

🇨🇦

London, Ontario, Canada

The Ottawa Hospital, Civic Campus

🇨🇦

Ottawa, Ontario, Canada

Sunnybrook & Women's College Health Sciences Centre

🇨🇦

Toronto, Ontario, Canada

Hôpital Maisonneuve-Rosemont

🇨🇦

Montreal, Quebec, Canada

Hôpital du Sacré-Coeur de Montréal

🇨🇦

Montreal, Quebec, Canada

University Health Network - Toronto General Hospital

🇨🇦

Toronto, Ontario, Canada

Centre Hospitalier de l'Université de Montréal - Hôpital Hôtel-Dieu

🇨🇦

Montreal, Quebec, Canada

Royal Victoria Hospital - McGill University Health Centre

🇨🇦

Montreal, Quebec, Canada

Centre Hospitalier Pierre-Boucher

🇨🇦

Longueuil, Quebec, Canada

Centre hospitalier affilié universitaire de Québec, Hôpital de l'Enfant-Jésus

🇨🇦

Quebec City, Quebec, Canada

Centre Hospitalier de l'Université de Montréal - Hôpital Notre Dame

🇨🇦

Montreal, Quebec, Canada

Montreal General Hospital - McGill University Health Centre

🇨🇦

Montreal, Quebec, Canada

Sir Mortimer B. Davis -Jewish General Hospital

🇨🇦

Montreal, Quebec, Canada

St. Mary's Hospital Center

🇨🇦

Montreal, Quebec, Canada

St. Joseph's Healthcare Hamilton

🇨🇦

Hamilton, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath